Female Infertility in India: Causes, Tests, and Your Path Forward

One in six couples in India faces difficulty conceiving. Among those, female factors account for approximately 40 to 50% of cases — either alone or in combination with a male factor. Yet despite how common female infertility is, many women spend months or years seeking answers before receiving a clear diagnosis and a coherent treatment plan.

This guide is a starting point for every woman who is struggling to conceive. It covers the major categories of female infertility, how each is investigated, and what the evidence says about treatment — giving you the foundation to have a more informed and productive conversation with your specialist.

How Infertility Is Defined

Infertility is defined as the failure to achieve a clinical pregnancy after 12 months of regular, unprotected sexual intercourse — or 6 months for women aged 35 and above. For women with known risk factors (previous pelvic surgery, irregular cycles, known PCOS or endometriosis), earlier investigation is appropriate without waiting for the 12-month threshold.

Subfertility — reduced fertility rather than complete inability to conceive — is more common than absolute infertility, and many subfertile couples do eventually conceive, either spontaneously or with support.

Category 1: Ovulatory Disorders

Problems with ovulation are the most common cause of female infertility, accounting for approximately 25 to 30% of cases. Without regular ovulation, there is no egg to fertilise — regardless of how good the sperm or how healthy the uterus.

PCOS — Polycystic Ovary Syndrome

PCOS is by far the most common cause of ovulatory infertility in India, affecting an estimated 20 to 25% of Indian women of reproductive age. In PCOS, the ovaries contain many small, immature follicles but fail to select and release one each cycle. The underlying driver in most cases is insulin resistance, which elevates androgens and disrupts the hormonal cascade that governs ovulation. Read the full guide on PCOS and fertility in our dedicated Pillar 3 article.

Hypothalamic Amenorrhoea

In women who are significantly underweight, exercising excessively, or under severe psychological stress, the brain's hormonal signalling to the ovaries can be suppressed. The result is absent or very irregular periods and anovulation. Treatment involves addressing the underlying cause — weight restoration, exercise moderation, and stress management.

Hyperprolactinaemia

Elevated prolactin — the hormone responsible for milk production — suppresses ovulation outside of pregnancy and breastfeeding. Common causes include a small benign pituitary tumour (prolactinoma) and certain medications. Treatment with dopamine agonists (cabergoline) is highly effective.

Thyroid Disorders

Both hypothyroidism and hyperthyroidism disrupt ovulation and increase miscarriage risk. Thyroid disorders are particularly common in Indian women, and TSH testing is a standard component of every female fertility workup.

Category 2: Tubal Factor Infertility

The fallopian tubes are the channel through which sperm travel to the egg, and through which the fertilised embryo travels to the uterus. Damage or blockage of the tubes — tubal factor infertility — accounts for approximately 25 to 30% of female infertility in India.

The most common cause of tubal damage is pelvic inflammatory disease (PID), most frequently caused by chlamydia or gonorrhoea — infections that can ascend silently from the vagina and cervix into the tubes, causing scarring and blockage. Previous pelvic surgery, endometriosis, and ectopic pregnancy treatment are other important causes.

IVF completely bypasses the fallopian tubes — making it the most effective treatment for tubal factor infertility in most patients. In selected cases (particularly where blockage is proximal and structural damage is limited), tubal surgery may be appropriate. A hydrosalpinx (blocked, fluid-filled tube) must always be addressed before IVF, as the toxic fluid significantly reduces implantation rates.

Category 3: Uterine and Endometrial Factors

The uterus must provide a receptive environment for embryo implantation and support pregnancy to term. Several structural and functional uterine conditions can impair this:

• Submucosal fibroids: Benign muscle growths that distort the uterine cavity, significantly impairing implantation even when small.
• Endometrial polyps: Localised overgrowths of the uterine lining — often asymptomatic but associated with implantation failure.
• Uterine septum: A congenital band of fibrous tissue dividing the cavity — the most common correctable structural cause of recurrent pregnancy loss.
• Intrauterine adhesions (Asherman's syndrome): Scarring of the cavity following uterine surgery or infection, reducing the functional area available for implantation.
• Thin endometrium: A persistently thin lining (below 6 to 7 mm at the time of transfer) is associated with poor implantation rates.

Most uterine structural problems are identified by ultrasound or hysteroscopy and are amenable to treatment — typically hysteroscopic surgery — before fertility treatment begins.

Category 4: Endometriosis

Endometriosis — the growth of tissue similar to the uterine lining outside the uterus — affects approximately 10% of women of reproductive age and up to 30 to 50% of infertile women. It impairs fertility through multiple mechanisms: distortion of pelvic anatomy, damage to ovarian reserve from endometriomas, creation of a hostile pelvic environment, and potential effects on endometrial receptivity.

Endometriosis is severely underdiagnosed in India — the average delay between symptom onset and diagnosis is 5 to 7 years. Symptoms include painful periods, deep pelvic pain, pain with intercourse, and sometimes no symptoms at all. Diagnosis requires laparoscopy. Treatment — surgical excision, hormonal suppression, or IVF — depends on the severity and the woman's fertility goals.

Category 5: Diminished Ovarian Reserve

Ovarian reserve refers to the quantity (and reflects the quality) of the remaining egg supply. Reserve declines with age — but can also be reduced prematurely by genetic factors, autoimmune conditions, previous ovarian surgery, or chemotherapy. Low AMH, elevated FSH, and a low antral follicle count on ultrasound are the hallmarks of diminished reserve.

Diminished reserve does not mean zero probability of natural conception or IVF success — but it means fewer eggs per stimulation cycle, less time before the window closes, and a lower probability per cycle than in women with normal reserve. Acting quickly when diminished reserve is identified is essential.

Category 6: Unexplained Infertility

When a full investigation — ovarian reserve, tubal patency, uterine structure, semen analysis, and hormonal profile — yields no identifiable cause, the diagnosis is unexplained infertility. This affects approximately 10 to 15% of infertile couples.

"Unexplained" does not mean "nothing is wrong." It means that current diagnostic tools have not identified the problem. IVF serves a dual role in unexplained infertility: it is both a treatment (taking fertilisation into the controlled laboratory environment) and a diagnostic tool (revealing problems in fertilisation or embryo development that standard tests cannot show).

The Female Fertility Investigation: What to Expect

A complete female fertility evaluation includes:

• Day 2 to 3 hormone panel: AMH, FSH, LH, oestradiol — to assess ovarian reserve and hormonal balance
• Prolactin and TSH — to exclude hyperprolactinaemia and thyroid disease
• Fasting glucose and insulin — particularly if PCOS is suspected
• Transvaginal ultrasound: uterine assessment, antral follicle count, detection of fibroids, polyps, or ovarian cysts
• Tubal assessment: HSG (hysterosalpingography) or HyCoSy as first-line; diagnostic laparoscopy with chromopertubation as gold standard when clinical suspicion is high
• Hysteroscopy: direct examination of the uterine cavity, where structural abnormality is suspected

The investigation should be structured and systematic — not ordered piecemeal over many months at multiple different clinics. At Solo Clinic, a complete female fertility evaluation is designed to reach a clear clinical picture efficiently, without unnecessary delay.

From Diagnosis to Treatment

Treatment in female infertility is entirely diagnosis-specific:

• Ovulatory disorders: Letrozole-based ovulation induction ± metformin for PCOS; dopamine agonists for hyperprolactinaemia; thyroid treatment; weight restoration for hypothalamic amenorrhoea
• Tubal factor: IVF as primary treatment; tubal surgery in selected cases; mandatory hydrosalpinx management before IVF
• Uterine factors: Hysteroscopic surgery for polyps, submucosal fibroids, septum, and adhesions before fertility treatment
• Endometriosis: Laparoscopic excision ± IVF depending on severity, age, and reserve
• Diminished reserve: Urgent, individualised IVF protocol; discussion of egg donation when reserve is critically low
• Unexplained: IUI for younger patients; IVF as first-line for those over 35 or with longer duration infertility

Frequently Asked Questions

Q1. At what age should I start worrying about female fertility?

Fertility begins to decline in the early thirties and accelerates after 35. If you are planning to start a family and are in your early thirties, it is worth having a baseline fertility assessment — AMH, AFC, and basic hormonal profile — even if you are not yet trying. This gives you information to plan around. If you are 35 or above and have been trying for 6 months without success, a full fertility evaluation is appropriate immediately.

Q2. Can lifestyle changes improve female fertility?

Yes — significantly in some areas. Achieving a healthy BMI (18.5 to 24.9) restores ovulation in a meaningful proportion of women with PCOS. Stopping smoking is the single highest-yield lifestyle change for egg quality and overall fertility. Adequate vitamin D, folic acid supplementation from preconception, and reducing alcohol all contribute. Lifestyle changes are not a substitute for medical treatment when a structural or hormonal cause has been identified — but they are a powerful complement.

Q3. Is female infertility always the woman's problem?

No. Infertility is a couple's diagnosis. Male factor infertility is present — either alone or in combination with female factors — in approximately 40 to 50% of infertile couples. A semen analysis for the male partner should always be part of the initial investigation, in parallel with female investigations — not as an afterthought.

Q4. How long does a complete female fertility investigation take?

A structured investigation — blood tests, ultrasound, hysterosalpingography, and a follow-up consultation to review all results — typically takes 4 to 6 weeks from the first appointment. If hysteroscopy or laparoscopy is indicated, additional time is needed. At Solo Clinic, the aim is to reach a complete, actionable diagnosis within one menstrual cycle where possible.

Q5. What if I want a second opinion on my infertility diagnosis?

Second opinions are always appropriate and are welcomed at Solo Clinic. Many couples arrive having received a diagnosis elsewhere without a clear explanation or treatment plan. Bring all your previous reports, cycle records, and investigation results — the more data available, the more accurate the second opinion.